Skip to content
healthcare.dev

Deferasirox

NDC 67877-552, Deferasirox, tablet, film coated, from Ascend Laboratories, LLC.

Product NDC
67877-552
Status
Listed
Labeler
Ascend Laboratories, LLC
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA210555
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67877-552 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEFERASIROX90 mg/1

Pharmacologic classes

Cytochrome P450 1A2 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Iron Chelating Activity [MoA]; Iron Chelator [EPC]

Package NDCNDC-11Package
67877-552-306787705523030 TABLET, FILM COATED in 1 BOTTLE (67877-552-30)
67877-552-906787705529090 TABLET, FILM COATED in 1 BOTTLE (67877-552-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0fb210b3-6a3d-4313-83ce-52012e384f9b

Use it

Look up 67877-552 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67877-552 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67877-552. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.